NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 14 filers reported holding NUVECTIS PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,184,614 | -21.0% | 142,040 | +22.0% | 0.09% | -27.9% |
| Q3 2023 | $1,500,138 | +4.3% | 116,380 | +29.2% | 0.13% | +9.3% |
| Q2 2023 | $1,438,274 | -23.7% | 90,061 | -37.4% | 0.12% | -28.0% |
| Q1 2023 | $1,885,218 | +88.6% | 143,800 | +7.9% | 0.16% | +80.2% |
| Q4 2022 | $999,750 | +6.0% | 133,300 | +0.2% | 0.09% | -30.0% |
| Q3 2022 | $943,000 | -30.4% | 133,000 | +9.9% | 0.13% | -26.1% |
| Q2 2022 | $1,355,000 | – | 121,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BALDWIN BROTHERS LLC/MA | 143,800 | $1,885,218 | 0.16% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 24,570 | $322,113 | 0.01% |
| Man Group plc | 12,840 | $168,332 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 164 | $2,150 | 0.00% |
| WELLS FARGO & COMPANY/MN | 25 | $328 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 35,022 | $459,138 | 0.00% |
| STATE STREET CORP | 13,400 | $175,674 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 24,667 | $323 | 0.00% |
| MORGAN STANLEY | 3,115 | $40,838 | 0.00% |